These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1681255)

  • 1. Immunoglobulin therapy.
    Finlayson JS; Tankersley DL
    Lancet; 1991 Oct; 338(8771):893-4. PubMed ID: 1681255
    [No Abstract]   [Full Text] [Related]  

  • 2. Passive transfer of hepatitis B surface antibodies from intravenous immunoglobulin.
    Freitas R; Sousa S; Cordeiro A; Godinho F
    Acta Reumatol Port; 2020; 45(2):155. PubMed ID: 32895359
    [No Abstract]   [Full Text] [Related]  

  • 3. Care of patients undergoing immunoglobulin therapy.
    Cochrane S
    Nurs Stand; 1997 Jul; 11(41):44-6. PubMed ID: 9283399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will sialylation change intravenous immunoglobulin therapy in the future?
    Käsermann F; Campbell IK
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):100-2. PubMed ID: 25546779
    [No Abstract]   [Full Text] [Related]  

  • 5. [Efficacy of intravenous human serum immune globulin for the prevention of post-transfusion hepatitis after open heart surgery].
    Sakamoto T; Nakahara H; Yokoyama M; Fujiwara H; Imazeki T; Matsunaga H; Suzuki T; Yamada T; Suzuki A; Onoda T
    Nihon Kyobu Geka Gakkai Zasshi; 1984 Nov; 32(11):1954-61. PubMed ID: 6084697
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary embolism associated with intravenous immunoglobulin therapy.
    Butler KS; Zeitlin DS
    Ann Pharmacother; 2003 Oct; 37(10):1530. PubMed ID: 14519037
    [No Abstract]   [Full Text] [Related]  

  • 7. Introduction.
    Gelfand EW
    Int Immunopharmacol; 2006 Apr; 6(4):515-6. PubMed ID: 16504912
    [No Abstract]   [Full Text] [Related]  

  • 8. Positive hepatitis serologies with treatment for Kawasaki syndrome.
    Borowitz SM
    Arch Dis Child; 1993 Jan; 68(1):151. PubMed ID: 8435007
    [No Abstract]   [Full Text] [Related]  

  • 9. Psoriasis improved by intravenous immunoglobulin therapy.
    Taguchi Y; Takashima S; Yoshida S; Dougu N; Inoue H; Tanaka K
    Intern Med; 2006; 45(14):879-80. PubMed ID: 16908947
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic use of immunoglobulins].
    Balint B; Ilić V; Taseski J; Andrić Z; Vucetić D
    Vojnosanit Pregl; 1999; 56(3):303-14. PubMed ID: 10518451
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intravenous and subcutaneous immunoglobulin therapy].
    Thon V
    Epidemiol Mikrobiol Imunol; 2013 Jul; 62(2):64-73. PubMed ID: 23964967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
    Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU
    Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immune globulin for passive tetanus prophylaxis.
    Bleck TP
    J Infect Dis; 1993 Feb; 167(2):498-9. PubMed ID: 8421191
    [No Abstract]   [Full Text] [Related]  

  • 15. Europe immunoglobulin map.
    Šedivá A; Chapel H; Gardulf A;
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):141-3. PubMed ID: 25546797
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravenous immunoglobulin.
    Goldhammer Y
    Neurology; 1992 Oct; 42(10):2053-4. PubMed ID: 1407594
    [No Abstract]   [Full Text] [Related]  

  • 17. Osmotic demyelination syndrome: variable clinical and radiologic response to intravenous immunoglobulin therapy.
    Murthy SB; Izadyar S; Dhamne M; Kass JS; Goldsmith CE
    Neurol Sci; 2013 Apr; 34(4):581-4. PubMed ID: 22491911
    [No Abstract]   [Full Text] [Related]  

  • 18. Relevance of quantitative measurements of anti-Abeta antibodies in therapeutic intravenous immunoglobulin using synthetic peptides.
    Jorquera JI
    Int Immunopharmacol; 2010 Mar; 10(3):373-4; author reply 375-6. PubMed ID: 20018258
    [No Abstract]   [Full Text] [Related]  

  • 19. High cost of immunoglobulin replacement therapy: Causes and implications.
    Sun D; Romberg N
    Ann Allergy Asthma Immunol; 2022 Nov; 129(5):645. PubMed ID: 36333061
    [No Abstract]   [Full Text] [Related]  

  • 20. Indications and safety of intravenous and subcutaneous immunoglobulin therapy.
    Rezaei N; Abolhassani H; Aghamohammadi A; Ochs HD
    Expert Rev Clin Immunol; 2011 May; 7(3):301-16. PubMed ID: 21595597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.